Published in BMC Med Genet on September 17, 2009
The dopamine transporter gene, a spectrum of most common risky behaviors, and the legal status of the behaviors. PLoS One (2010) 0.91
Monoamine transporters: vulnerable and vital doorkeepers. Prog Mol Biol Transl Sci (2011) 0.87
Genetic influence of dopamine receptor, dopamine transporter, and nicotine metabolism on smoking cessation and nicotine dependence in a Japanese population. BMC Genet (2014) 0.83
Meta-analysis reveals significant association of 3'-UTR VNTR in SLC6A3 with smoking cessation in Caucasian populations. Pharmacogenomics J (2015) 0.77
Genetic analysis of polymorphisms in dopamine receptor and transporter genes for association with smoking among cancer patients. Eur Addict Res (2012) 0.77
Gene-based and pathway-based genome-wide association study of alcohol dependence. Shanghai Arch Psychiatry (2015) 0.75
The Fagerström Test for Nicotine Dependence: a revision of the Fagerström Tolerance Questionnaire. Br J Addict (1991) 63.91
Sifting the evidence-what's wrong with significance tests? BMJ (2001) 9.50
Allelic association of human dopamine D2 receptor gene in alcoholism. JAMA (1990) 5.04
A meta-analysis of estimated genetic and environmental effects on smoking behavior in male and female adult twins. Addiction (2003) 4.37
Evidence suggesting the role of specific genetic factors in cigarette smoking. Health Psychol (1999) 3.56
Smoking status and the human dopamine transporter variable number of tandem repeats (VNTR) polymorphism: failure to replicate and finding that never-smokers may be different. Nicotine Tob Res (2002) 3.19
Nicotine activates and desensitizes midbrain dopamine neurons. Nature (1997) 3.02
A twin study of genetic and environmental influences on tobacco initiation, regular tobacco use and nicotine dependence. Psychol Med (2004) 2.98
Polymorphisms in the dopamine D2 receptor gene and their relationships to striatal dopamine receptor density of healthy volunteers. Mol Psychiatry (1999) 2.90
Identification and characterization of ANKK1: a novel kinase gene closely linked to DRD2 on chromosome band 11q23.1. Hum Mutat (2004) 2.89
Human dopamine transporter gene (DAT1) maps to chromosome 5p15.3 and displays a VNTR. Genomics (1992) 2.55
Allelic association of the D2 dopamine receptor gene with receptor-binding characteristics in alcoholism. Arch Gen Psychiatry (1991) 2.30
Genotype influences in vivo dopamine transporter availability in human striatum. Neuropsychopharmacology (2000) 2.28
D2 dopamine receptor gene (DRD2) Taq1 A polymorphism: reduced dopamine D2 receptor binding in the human striatum associated with the A1 allele. Pharmacogenetics (1997) 2.28
The human dopamine D2 receptor gene is located on chromosome 11 at q22-q23 and identifies a TaqI RFLP. Am J Hum Genet (1989) 2.25
Case-control study of the D2 dopamine receptor gene and smoking status in lung cancer patients. J Natl Cancer Inst (1998) 2.16
Increased dopamine transporter availability associated with the 9-repeat allele of the SLC6A3 gene. J Nucl Med (2005) 1.89
The dopamine D2 receptor (DRD2) gene: a genetic risk factor in smoking. Pharmacogenetics (1996) 1.81
A genetic association for cigarette smoking behavior. Health Psychol (1999) 1.69
Non-replication of genetic association studies: is DAT all, folks? Nicotine Tob Res (2002) 1.50
D2 dopamine receptor gene and cigarette smoking: a reward gene? Med Hypotheses (1994) 1.42
Elucidating the role of genetic factors in smoking behavior and nicotine dependence. Am J Med Genet B Neuropsychiatr Genet (2003) 1.40
Abuse liability and pharmacodynamic characteristics of intravenous and inhaled nicotine. J Pharmacol Exp Ther (1985) 1.32
Effects of dopamine transporter and receptor polymorphisms on smoking cessation in a bupropion clinical trial. Health Psychol (2003) 1.32
D2 dopamine receptor gene and obesity. Int J Eat Disord (1994) 1.30
The variable number of tandem repeats polymorphism of the dopamine transporter gene is not associated with significant change in dopamine transporter phenotype in humans. Neuropsychopharmacology (2001) 1.28
The dopamine transporter gene (SLC6A3) variable number of tandem repeats domain enhances transcription in dopamine neurons. J Neurochem (2001) 1.27
Stress-induced cigarette craving: effects of the DRD2 TaqI RFLP and SLC6A3 VNTR polymorphisms. Pharmacogenomics J (2004) 1.09
Association of smoking and personality with a polymorphism of the dopamine transporter gene: results from a community survey. Am J Med Genet (2000) 1.05
High levels of dopamine activity in the basal ganglia of cigarette smokers. Am J Psychiatry (2000) 1.00
The effects of the DRD2 polymorphism on smoking cessation and negative affect: evidence for a pharmacogenetic effect on mood. Nicotine Tob Res (2004) 0.99
Family-based study of the association of the dopamine D2 receptor gene (DRD2) with habitual smoking. Am J Med Genet (2000) 0.98
Association between the dopamine D2 receptor A2/A2 genotype and smoking behavior in the Japanese. Cancer Epidemiol Biomarkers Prev (2001) 0.92
The dopamine D2 receptor C32806T polymorphism (DRD2 Taq1A RFLP) exhibits no association with smoking behaviour in a healthy UK population. Addict Biol (2004) 0.90
Association between smoking habits and dopamine receptor D2 taqI A A2 allele in Japanese males: a confirmatory study. J Epidemiol (2002) 0.88
A 40-nucleotide repeat polymorphism in the human dopamine transporter gene. Hum Genet (1993) 0.88
Lack of association between the dopamine D2 receptor gene allele DRD2*A1 and cigarette smoking in a United Kingdom population. Pharmacogenetics (1998) 0.85
Lack of effect of D2 dopamine receptor TaqI A polymorphism on smoking cessation. Nicotine Tob Res (2005) 0.83
Can pharmacogenetics help smokers quit? Pharmacogenomics (2006) 0.78
BRCA1: a novel prognostic factor in resected non-small-cell lung cancer. PLoS One (2007) 1.86
Three-gene expression signature predicts survival in early-stage squamous cell carcinoma of the lung. Clin Cancer Res (2008) 1.62
[Reccomendation of Polish Respiratory Society for palliative care in chronic lung diseases]. Pneumonol Alergol Pol (2012) 1.48
[Medical students' attitudes towards tobacco smoking at the first and sixth year of their studies 2002-2008]. Pneumonol Alergol Pol (2009) 1.42
Analysis of the differences in whole-genome expression related to asthma and obesity. Pol Arch Med Wewn (2015) 1.39
Association between sensitization to Aureobasidium pullulans (Pullularia sp) and severity of asthma. Ann Allergy Asthma Immunol (2007) 1.32
Integration of gene dosage and gene expression in non-small cell lung cancer, identification of HSP90 as potential target. PLoS One (2008) 1.14
Prisoners' attitudes towards cigarette smoking and smoking cessation: a questionnaire study in Poland. BMC Public Health (2006) 1.13
Patterns of motivations and ways of quitting smoking among Polish smokers: a questionnaire study. BMC Public Health (2008) 0.99
Air humidity may influence the aerosol distribution of normal saline administered by closed or vented nebulizers operated continuously or dosimetrically. J Aerosol Med Pulm Drug Deliv (2009) 0.97
MDM2 gene amplification: a new independent factor of adverse prognosis in non-small cell lung cancer (NSCLC). Lung Cancer (2004) 0.93
[Cancer related fatigue. I. Prevalence and attempt to define the problem]. Pol Merkur Lekarski (2004) 0.90
[Recommendations of the Polish Society of Lung Diseases for diagnosis and treatment of chronic obstructive pulmonary disease (COPD)]. Pneumonol Alergol Pol (2012) 0.87
Main histologic types of non-small-cell lung cancer differ in expression of prognosis-related genes. Clin Lung Cancer (2013) 0.86
Analysis of safety, risk factors and pretreatment methods during rush hymenoptera venom immunotherapy. Int Arch Allergy Immunol (2008) 0.86
Prognostic value of cyclin D1 overexpression in correlation with pRb and p53 status in non-small cell lung cancer (NSCLC). J Cancer Res Clin Oncol (2005) 0.86
YKL-40 protein is a marker of asthma. J Asthma (2011) 0.86
[Quality of life of patients with asthma which has been well and poorly controlled]. Pneumonol Alergol Pol (2007) 0.84
Diagnosis of Mastocytosis in Children and Adults in Daily Clinical Practice. Acta Derm Venereol (2016) 0.83
Novel, activating KIT-N822I mutation in familial cutaneous mastocytosis. Exp Hematol (2011) 0.83
A portable automatic cough analyser in the ambulatory assessment of cough. Biomed Eng Online (2010) 0.83
Loss of heterozygosity at chromosomes 3p and 17p in primary non-small cell lung cancer. Anticancer Res (2005) 0.82
Late-phase allergic reaction in nasal provocation with fungal allergens. Allergy Asthma Proc (2008) 0.82
Chlamydophila pneumoniae, Mycoplasma pneumoniae infections, and asthma control. Allergy Asthma Proc (2011) 0.82
[Polish respiratory society guidelines for chronic obstructive pulmonary disease]. Pneumonol Alergol Pol (2014) 0.81
Lack of association between serotonin transporter gene polymorphism 5-HTTLPR and smoking among Polish population: a case-control study. BMC Med Genet (2008) 0.80
European Competence Network on Mastocytosis (ECNM): 10-year jubilee, update, and future perspectives. Wien Klin Wochenschr (2012) 0.80
Changes in gene expression caused by insect venom immunotherapy responsible for the long-term protection of insect venom-allergic patients. Ann Allergy Asthma Immunol (2011) 0.80
Increased risk of non-small cell lung cancer and frequency of somatic TP53 gene mutations in Pro72 carriers of TP53 Arg72Pro polymorphism. Lung Cancer (2006) 0.80
[Style of coping with stress and emotional functioning in patients with asthma]. Pneumonol Alergol Pol (2009) 0.80
Comparative analysis of IL6 and IL6 receptor gene polymorphisms in mastocytosis. Br J Haematol (2012) 0.80
Polish medical students' perceptions of the nursing profession: a cross-sectional study. Scand J Caring Sci (2008) 0.79
[Lung microangiopathy in diabetes]. Pneumonol Alergol Pol (2009) 0.78
Gene expression analysis in predicting the effectiveness of insect venom immunotherapy. J Allergy Clin Immunol (2010) 0.78
Risk factors for anaphylaxis in patients with mastocytosis. Pol Arch Med Wewn (2015) 0.77
Factors influencing adherence to treatment in COPD patients and its relationship with disease exacerbations. Pneumonol Alergol Pol (2014) 0.77
The angiotensinogen AGT p.M235T gene polymorphism may be responsible for the development of severe anaphylactic reactions to insect venom allergens. Int Arch Allergy Immunol (2010) 0.76
Opioid receptor bronchial tree: current science. Curr Opin Support Palliat Care (2014) 0.76
Prognostic relevance of altered pRb and p53 protein expression in surgically treated non-small cell lung cancer patients. Oncology (2004) 0.76
Absence of prognostic significance of p21(WAF1/CIP1) protein expression in non-small cell lung cancer. Acta Oncol (2005) 0.76
YKL-40 protein correlates with the phenotype of asthma. Lung (2015) 0.76
[Side effects of specific immunotherapy in patients with hymenoptera venom allergy]. Pneumonol Alergol Pol (2005) 0.76
Gene expression analysis in allergology: the prediction of Hymenoptera venom allergy severity and treatment efficacy. Clin Transl Allergy (2013) 0.76
[Tobacco smoking among the first-year medical students]. Pneumonol Alergol Pol (2006) 0.75
Asthma control uncontrolled. Pol Arch Med Wewn (2015) 0.75
Intima-media thickness in patients with obstructive sleep apnea without comorbidities. Lung (2013) 0.75
The osteocalcin gene rs1800247 polymorphism in Kashubian population. Rheumatol Int (2012) 0.75
Typing safe antibiotics in amoxicillin hypersensitive patients - development of a stepwise protocol. Pneumonol Alergol Pol (2016) 0.75
Pregranulomatous phase of sarcoidosis: immunohistochemical diagnosis. Acta Histochem (2005) 0.75
Transthoracic lung ultrasonography in pulmonary alveolar proteinosis - case report. Sarcoidosis Vasc Diffuse Lung Dis (2013) 0.75
[Chemotherapy of advanced non-small cell lung cancer with the combination of gemcitabine and cisplatin]. Pneumonol Alergol Pol (2002) 0.75
The statement of the Polish Society of Allergology experts on the treatment of difficult-to-treat asthma. Pneumonol Alergol Pol (2015) 0.75
[COPD, lung cancer--a common molecular pathway?]. Pneumonol Alergol Pol (2013) 0.75
[Diagnosis and treatment of tobacco dependence]. Pneumonol Alergol Pol (2005) 0.75
[Systemic mastocytosis]. Pneumonol Alergol Pol (2005) 0.75
Clinical value of conjunctival allergen challenge in diagnosing allergic conjunctivitis related to latex. Int Arch Allergy Immunol (2010) 0.75
[Usefulness of exercise test and peak inspiratory flow (PIF) measurement in diagnosis and management of bronchial asthma]. Pneumonol Alergol Pol (2004) 0.75
Prognostic value of the apoptotic index analysed jointly with selected cell cycle regulators and proliferation markers in non-small cell lung cancer. Lung Cancer (2009) 0.75
[Analysis of deaths caused by obstructive pulmonary diseases in Pomerania province in 2001-2004]. Pneumonol Alergol Pol (2007) 0.75
[The prevalence of tobacco smoking among Polish Pallotins priests and seminarians of Seminary in Ołtarzew]. Pneumonol Alergol Pol (2004) 0.75
Persistent impact of cigarette smoking on asthma. J Asthma (2008) 0.75
Unusual diagnosis hidden by poorly controlled asthma. Kardiol Pol (2017) 0.75
P53 and K-ras mutations are frequent events in microscopically negative surgical margins from patients with nonsmall cell lung carcinoma. Cancer (2004) 0.75
[Coexistence of sarcoidosis with seminoma--a case report]. Pneumonol Alergol Pol (2013) 0.75
Diabetic pulmonary microangiopathy - fact or fiction? Endokrynol Pol (2011) 0.75
[Treatment of pulmonary hypertension]. Wiad Lek (2007) 0.75
Asthma prevalence and risk factors analysis in Tricity university students' group. Pneumonol Alergol Pol (2015) 0.75
[Alterations of locus P16INK4a/P14ARF in non-small cell lung cancer]. Pneumonol Alergol Pol (2003) 0.75
[Assessment of exercise test and bronchial reversibility test as tools for asthma diagnosis in patients with normal spirometry]. Przegl Lek (2006) 0.75
Changes in the Expression of MicroRNA in the Buildup Phase of Wasp Venom Immunotherapy: A Pilot Study. Int Arch Allergy Immunol (2016) 0.75
[Accuracy of spirometry performed by general practitioners and pulmonologists in Pomeranian Region in the "Prevention of COPD" NHS program]. Pneumonol Alergol Pol (2009) 0.75
[Analysis of prognostic value of TP53 gene mutations in non-small cell lung cancer]. Pneumonol Alergol Pol (2005) 0.75
[Chronic obstructive pulmonary disease in women]. Pneumonol Alergol Pol (2012) 0.75
Interleukin-31 Polymorphisms and Serum IL-31 Level in Patients with Mastocytosis: Correlation with Clinical Presen-tation and Pruritus. Acta Derm Venereol (2017) 0.75
[Serum eosinophil cationic protein (ECP) in patients with perennial rhinitis and atopic dermatitis, allergic to house dust mites]. Pol Merkur Lekarski (2005) 0.75
[Latent tetany masked by syndroms of bronchial asthma and depressive syndrome. Case report]. Pneumonol Alergol Pol (2006) 0.75
The negative predictive value of typing safe local anesthetics. Int Arch Allergy Immunol (2013) 0.75
Modern management of symptoms and quality of life. Curr Probl Cancer (2003) 0.75
[Serum anti-P53 antibodies (AB-anti-P53) in patients with advanced non-small cell lung cancer (NSCLC)]. Pneumonol Alergol Pol (2002) 0.75
Clinical value of conjunctival allergen challenge in diagnosing allergic conjunctivitis related to latex. J Allergy Clin Immunol (2007) 0.75
[The prevalence of serum IgG antibodies against HTLV viruses type I and II in sarcoidosis patients]. Pneumonol Alergol Pol (2002) 0.75
Tracheobronchopathia osteochondroplastica—case report and literature review. Pneumonol Alergol Pol (2015) 0.75
Does the aberrant expression of CD2 and CD25 by skin mast cells truly correlate with systemic involvement in patients presenting with mastocytosis in the skin? Int Arch Allergy Immunol (2014) 0.75
[Results of treatment for chronic pleural empyema]. Pneumonol Alergol Pol (2003) 0.75
[Hyperlucent lung syndrom caused by pulmonary artery hypoplasia in patient with diagnosed asthma--case report]. Pol Merkur Lekarski (2008) 0.75